Marshall Wace’s Imunon IMNN Stock Holding History

Marshall Wace’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-662	Closed	-$179K	–	2838
2021 Q1	$179K	Buy	+662	New	+$222K	﹤0.01%	2291

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's IMNN Position: Q2 2021 in Review

Marshall Wace sold out of Imunon (IMNN) in Q2 2021, closing a stake of 662 shares — an estimated $179K sold.

Marshall Wace first reported a position in IMNN in Q1 2021 and held it in 1 quarter. The position peaked at $179K in Q1 2021. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2021.

Marshall Wace reported no remaining Imunon position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 662 Imunon shares in Q2 2021, an estimated $179K.
Marshall Wace first reported a position in Imunon in Q1 2021 and held it in 1 quarter.
Marshall Wace's Imunon position peaked at $179K in Q1 2021.
37 funds tracked by Wall St. Rank held Imunon as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.